This half day course will look at the practicalities of research in settings where prospective consent is not possible for reasons such as lack of capacity. This is due to the urgency of the situation as a result of a life threatening or other serious medical condition such as:
within the critical care setting, emergency care, obstetrics and paediatrics
As a definition/descriptor of deferred consent, the following paragraph has been taken directly from the Medicines for Human Use (Clinical Trials) Regulations 2006 No. 2984, explanatory memorandum
‘These Regulations amend the Medicines for Human Use (Clinical Trials) Regulations 2004 to provide an exception to the general rule that incapacitated adults can only participate in trials after the consent of their legal representative (as defined) has been obtained. The exception will apply in the context of trials of emergency medicines only e.g. first line treatment of cardiac arrest or car crash victims. The amendment will facilitate research into potentially life-saving emergency medicines in the UK.’
The day will be in the form of a workshop with sessions delivered by research experts within their field of practice, all will have first-hand experiences and information to share with delegates
Please note a certificate of attendance will only be issued if delegates complete all elements of the training.
Following the training, participants will:
Search for this course here